ANTI-TUMOR EFFICACY OF B. SUBTILIS IMV B-7724 LECTIN IN RATS BEARING CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT GUÉRIN’S CARCINOMA
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-23-3-2021-g.9781Keywords:
anti-tumor efficacy, bacterial lectin, chemoresistance, Guérin’s carcinomaAbstract
Aim: to investigate anti-tumor efficacy of extracellular B. subtilis IMV B-7724 lectin alone or in combination with cisplatin in rats bearing cisplatin-sensitive or cisplatin-resistant Guérin’s carcinoma. Object and methods: in the experiments, Wistar rats were used. Cisplatin-sensitive (CIS) and -resistant strains of Guérin’s carcinoma (GC) were used as models of tumor growth. The treatment of the tumor-bearing animals began on day 7 of tumor growth and included immunotherapy or a combination of immunotherapy with subsequent (on day 14 of tumor growth) chemotherapy. The lectin of B. subtilis IMV B-7724 was applied as means of immunotherapy; cisplatin was used in the schemes including chemotherapy. The antitumor effect of the applied therapeutic schemes was evaluated according to standard parameters of tumor growth: tumor volume, survival rate, tumor growth inhibition (TGI), tumor volume doubling time (TVDT), frequency of animals with tumor regression (FTR). The statistical analysis of the results was conducted according to the generally accepted methods of variation statistics. The survival rate of the animals was estimated by the Kaplan — Meier method. The difference was considered as significant at p < 0.05. Results: regardless of the sensitivity of the tumor strain to cisplatin, immunotherapy had a pronounced antitumor effect. It is worth mentioning that in the rats bearing cisplatin-sensitive GC, the most notable antitumor efficacy was registered in the group which underwent the combined treatment (immunotherapy followed by chemotherapy): TGI = 99.9%; TVDT21-29; 29-36 = -0.91; -3.57; FTR36 ≥55.6%. On the contrary, in the rats bearing cisplatin-resistant GC the most significant results were in the group receiving immunotherapy only: TGI = 100.0%; TVDT21-29; 29-36 = 0; 0; FTR36 ≥66.7%. Conclusions: applied as a means of immunotherapy to rats bearing cisplatin-resistant experimental tumor, B. subtilis IMV B-7724 lectin demonstrated a pronounced antitumor effect. In the case of cisplatin-sensitive experimental tumor, it is preferable to combine immunotherapy with cisplatin.
References
Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem 2019; 88: 102925.
Cancer in Ukraine, 2019–2020. Incidence, mortality, prevalence and other relevant statistic. Bull Natl Cancer Register Ukr; Kyiv, 2021; 22: http://www.ncru.inf.ua/publications/BULL_22. (in Ukrainian)
Zhu H, Luo H, Zhang W, et al. Molecular mechanisms of cisplatin resistance in cervical cancer. Drug Des Devel Ther 2016; 10: 1885–95.
Schultz MJ, Swindall AF, Wright JW, et al. ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells. J Ovarian Research 2013; 6: 25.doi:10.1186/1757-2215-6-25.
Potebnya G, Cheremshenko N, Lisovenko G, et al. Antitumor efficacy of autovaccines prepared from chemoresistant tumor cells with the use of lectin of B. subtilis B-7025. Exp Oncol 2007; 29 (4): 277–80.
Munkley J, Elliott DJ. Hallmarks of glycosylation in cancer. Oncotarget 2016; 7 (23): 35478–89.
Yue Zhangab, Ruohan Wangab, Ying Fengc, Fang Maab. The role of sialyltransferases in gynecological malignant tumors. Life Sciences 2020; 263: 118670. doi.org/10.1016/j.lfs.2020.118670.
Wichert B, Milde-Langosch K, Galatenko V, et al. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer. Glycobiology 2018; 28 (11): 898–903. doi.org/10.1093/glycob/cwy065.
Xiaoman Zhou, Ganglong Yang, Feng Guan. Biological functions and analytical strategies of sialic acids in tumor. Cells 2020; 9 (273); doi:10.3390/cells9020273.
Dobie C, Skropeta D. Insights into the role of sialylation in cancer progression and metastasis. Brit J Cancer 2020; doi.org/10.1038/s41416-020-01126-7.
Antonyuk VO. Lectins and their raw sources. Lviv: PE «Quart», 2005. 554 p. (in Ukrainian).
Nathan Sharon HL. Lectins: functions. Springer: Science & Business Media, 2007: 333–66.
Pervin MKY, Isemura M, Nakamura Y. Plant lectins in therapeutic and diagnostic cancer research. Int J Plant Biol Res 2015; 3: 1–6.
Karaman OM, Fedosova NI, Voeikova IM, et al. Perspectives of using lectins for cancer diagnostic and treatment. Oncologia 2018; 20 (1): 10–6. (in Ukrainian).
Podgorsky VS, Kovalenko EA, Karpova IS, et al. Extracellular lectins of saprophytic strains of bacteria of the genus Bacillus (review). Applied Biochem Microbiol 2014; 50 (3): 256–63.
Potebnya GP, Tanasienko OA, Cheremshenko NL, et al. Means to receive the substances with antitumor activity. Patent № 59472 Ukraine; Publ 15.09.2003; Bull № 9 (In Ukrainian).
Cheremshenko NL, Fedosova NI, Hetman KI, et al. Cytotoxic lectin with antitumor activity. Utility model patent № 141944 (UA)/(Ukraine); Publ. 12.05.2020, Bull №9. (in Ukrainian).
Experimental evaluation of anticancer drugs in the USSR and the USA. Eds. Z.P. Sofyina, A.B. Syrkin, A. Goldin, A. Klein. M: Medicine, 1979. 296 p. (in Russian).
Yurchenko OV, Todor IN, Tryndyak VP, et al. Resistance of Guerinís carcinoma cells to cisplatine: biochemical and morphological aspects. Exp Oncol 2003; 25: 64–8.
Lukianova NYu, Borikun TV, Demash DV, et al. Changes in the range of metalloproteins and their regulatory factors in growth dynamic of sensitive and resistant Guerin carcinoma. Oncologia 2016; 18 (4): 247–54. (In Ukrainian)
Law of Ukraine No. 3447-IV. On the protection of animals from cruelty.
Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes (OJ L 276, 20.10.2010, p. 33).
Sharykina NO, Shlyakhovenko VO, Mosienko VS, et al. Preclinical study of specific activity of antitumor drugs. In: Preclinical studies of drugs (guidelines). Ed. OV Stefanova. К: Avitsena, 2001: 361–70.
Li J, Xia T, Yang X, et al. Malignant solitary pulmonary nodules: assessment of mass growth rate and doubling time at follow-up CT. J Thorac Dis 2018; 10 (Suppl 7): S797-S806.
Sidenko AB, Vishnyakov VV, Isaev SM. Theory of statistics. М: MAX-Press, 2011. 343 p. (in Russian)
Symchych TV, Fedosova NI, Chumak AV, et al. Functions of tumor-associated macrophages and macrophages residing in remote anatomical niches in Ehrlich carcinoma bearing mice. Exp Oncol 2020; 42 (3): 197–203.
